ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – EGRX
December 19, 2023 21:11 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle...
MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholders
December 19, 2023 13:29 ET
|
Johnson Fistel, LLP
SAN DIEGO, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, is investigating potential securities claims against Morphic Holding, Inc. (NASDAQ: MORF) on behalf of stockholders. The investigation...
EAGLE PHARMACEUTICALS ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
December 19, 2023 09:30 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
December 17, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
Kaplan Fox & Kilsheimer LLP Reminds Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline
December 17, 2023 08:01 ET
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox alerts investors of class action and upcoming deadline.
DEADLINE ALERT for EH and EGRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 15, 2023 12:06 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
EAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
December 15, 2023 09:30 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
Eagle Pharmaceuticals Investor Update: Kaplan Fox & Kilsheimer LLP Notifies Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline
December 13, 2023 12:30 ET
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox notifies investors of Class Action filed against Eagle Pharmaceuticals.
EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Eagle Pharmaceuticals, Inc. on Behalf of Eagle Pharmaceuticals Stockholders and Encourages Investors to Contact the Firm
December 10, 2023 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Eagle Pharmaceuticals,...
EGRX Investor Alert: Kaplan Fox & Kilsheimer LLP Investigates Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX)
December 07, 2023 08:00 ET
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Eagle Pharmaceuticals, Inc.